Petroleo Brasileiro SA Petrobras
PBR
Strategy
MSTR
Vale SA
VALE
KB Home
KBH
Apple
AAPL
US Stock MarketDetailed Quotes
IMRX Immuneering
- 1.860
- 0.0000.00%
Close Feb 14 16:00 ET
- 1.860
- 0.0000.00%
Post 20:01 ET
57.75MMarket Cap-0.94P/E (TTM)
1.920High1.850Low169.95KVolume1.900Open1.860Pre Close319.01KTurnover0.76%Turnover RatioLossP/E (Static)31.05MShares7.68052wk High1.00P/B41.66MFloat Cap1.00052wk Low--Dividend TTM22.40MShs Float33.990Historical High--Div YieldTTM3.76%Amplitude1.000Historical Low1.877Avg Price1Lot Size
About Immuneering Company
Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that have eluded conventional approaches, including cancer cachexia and metastasis. The company was founded by Robert J. Carpenter and Benjamin J. Zeskind in 2008 and is headquartered in Cambridge, MA.
Company Profile
SymbolIMRX
Company NameImmuneering
Listing DateJul 30, 2021
Issue Price15.00
Founded2008
CEODr. Benjamin J. Zeskind, PhD
MarketNASDAQ
Employees68
Fiscal Year Ends12-31
Address245 Main Street,2nd floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-500-8080
Websitehttp://www.immuneering.com
Company Executives
- Name
- Position
- Salary
- Dr. Benjamin J. Zeskind, PhD
- President, Chief Executive Officer and Director
- 1.92M
- Harold Eugene Brakewood
- Chief Business Officer
- 1.47M
- Leah R. Neufeld
- Chief People Officer
- --
- Michael D. Bookman
- Chief Legal Officer and Secretary
- --
- Mallory Morales
- Chief Accounting Officer, Principal Financial Officer and Treasurer
- --
- Dr. Brett Hall, PhD
- Chief Scientific Officer
- 1.40M
- Ann E. Berman
- Chairman of the Board and Lead Independent Director
- 181.38K
- Dr. Thomas J. Schall, PhD
- Director
- --
- Peter Feinberg
- Independent Director
- 165.67K
- Dr. Diana F. Hausman, M.D.
- Independent Director
- 175.38K
- Laurie B. Keating, J.D.
- Independent Director
- 179.88K
- Robert J. Carpenter
- Independent Director
- 202.74K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.